Phase 1 Trial of Gefitinib Plus Sirolimus in Adults with Recurrent Malignant Glioma - Concepedia

Concepedia

Publication | Closed Access

Phase 1 Trial of Gefitinib Plus Sirolimus in Adults with Recurrent Malignant Glioma

191

Citations

37

References

2006

Year

David A. Reardon, Jennifer A. Quinn, James J. Vredenburgh, Sridharan Gururangan, Allan H. Friedman, Annick Desjardins, Sith Sathornsumetee, James E. Herndon, Jeannette M. Dowell, Roger E. McLendon,

Clinical Cancer Research

Abstract

We show that gefitinib plus sirolimus can be safely coadministered on a continuous, daily dosing schedule, and established the recommended dose level of these agents in combination for future phase 2 clinical trials.

References

	Year	Citations

Page 1